Kathleen Kahler Fonda

Array ( [id] => 3412513 [patent_doc_number] => 05461143 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-24 [patent_title] => 'Oligosaccharide enzyme substrates and inhibitors: methods and compositions' [patent_app_type] => 1 [patent_app_number] => 8/219242 [patent_app_country] => US [patent_app_date] => 1994-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39317 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/461/05461143.pdf [firstpage_image] =>[orig_patent_app_number] => 219242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3519612 [patent_doc_number] => 05529986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Conjugate, its preparation and use and a substrate prepared with the conjugate' [patent_app_type] => 1 [patent_app_number] => 8/211224 [patent_app_country] => US [patent_app_date] => 1994-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7493 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/529/05529986.pdf [firstpage_image] =>[orig_patent_app_number] => 211224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731069 [patent_doc_number] => 05693625 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Method of regenerating cells and tissues using functionalized dextrans' [patent_app_type] => 1 [patent_app_number] => 8/216859 [patent_app_country] => US [patent_app_date] => 1994-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6808 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693625.pdf [firstpage_image] =>[orig_patent_app_number] => 216859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241168 [patent_doc_number] => 06090928 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Process for the preparation and work-up of N-hydroxyalkylchitosans soluble in aqueous medium' [patent_app_type] => 1 [patent_app_number] => 8/217189 [patent_app_country] => US [patent_app_date] => 1994-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3098 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090928.pdf [firstpage_image] =>[orig_patent_app_number] => 217189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3426047 [patent_doc_number] => 05459249 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-17 [patent_title] => 'Process for continuous manufacture of alkylglycosides' [patent_app_type] => 1 [patent_app_number] => 8/214630 [patent_app_country] => US [patent_app_date] => 1994-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/459/05459249.pdf [firstpage_image] =>[orig_patent_app_number] => 214630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3482817 [patent_doc_number] => 05405949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-11 [patent_title] => 'Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the .alpha.-L-iduronic-2-O-sulfate acid' [patent_app_type] => 1 [patent_app_number] => 8/206980 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2678 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 391 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/405/05405949.pdf [firstpage_image] =>[orig_patent_app_number] => 206980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3116743 [patent_doc_number] => 05410039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-04-25 [patent_title] => 'Process for the synthesis of glycosaminoglycans containing .alpha.-L-galacturonic acid substituted with nucleophilic groups in position 3' [patent_app_type] => 1 [patent_app_number] => 8/207140 [patent_app_country] => US [patent_app_date] => 1994-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2675 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 407 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/410/05410039.pdf [firstpage_image] =>[orig_patent_app_number] => 207140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3505867 [patent_doc_number] => 05514668 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Composition for removing or inactivating harmful components in blood or other extracellular body fluids' [patent_app_type] => 1 [patent_app_number] => 8/205629 [patent_app_country] => US [patent_app_date] => 1994-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5974 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514668.pdf [firstpage_image] =>[orig_patent_app_number] => 205629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3684367 [patent_doc_number] => 05633357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Synthesis of carboxylic acid glucuronides' [patent_app_type] => 1 [patent_app_number] => 8/206019 [patent_app_country] => US [patent_app_date] => 1994-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22853 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633357.pdf [firstpage_image] =>[orig_patent_app_number] => 206019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3550510 [patent_doc_number] => 05547944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it' [patent_app_type] => 1 [patent_app_number] => 8/199229 [patent_app_country] => US [patent_app_date] => 1994-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4761 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547944.pdf [firstpage_image] =>[orig_patent_app_number] => 199229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3102826 [patent_doc_number] => 05447917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-05 [patent_title] => 'D-tagatose as anti-hyperglycemic agent' [patent_app_type] => 1 [patent_app_number] => 8/190938 [patent_app_country] => US [patent_app_date] => 1994-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1760 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/447/05447917.pdf [firstpage_image] =>[orig_patent_app_number] => 190938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3411985 [patent_doc_number] => 05438133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-01 [patent_title] => 'Cyclodextrin catenane compounds capable of forming inclusion complexes' [patent_app_type] => 1 [patent_app_number] => 8/190010 [patent_app_country] => US [patent_app_date] => 1994-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7094 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/438/05438133.pdf [firstpage_image] =>[orig_patent_app_number] => 190010 [rel_patent_id] =>[rel_patent_doc_number] =>)